SIGA Technologies, Inc. (SIGA)
Largest Insider Buys in Sector
SIGA Stock Price History Chart
SIGA Stock Performance
About SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Insider Activity of SIGA Technologies, Inc.
Over the last 12 months, insiders at SIGA Technologies, Inc. have bought $0 and sold $0 worth of SIGA Technologies, Inc. stock.
On average, over the past 5 years, insiders at SIGA Technologies, Inc. have bought $0 and sold $223,800 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $44,200 was made by Gomez Phillip Louis III () on 2019‑12‑09.
List of Insider Buy and Sell Transactions, SIGA Technologies, Inc.
| 2021-12-09 | Sale | director | 30,000 0.0401% | $7.82 | $234,600 | +23.56% | ||
| 2020-08-27 | Sale | 30,000 0.0385% | $7.10 | $213,000 | -3.67% | |||
| 2019-12-09 | 10,000 0.0125% | $4.42 | $44,200 | +35.32% | ||||
| 2019-12-09 | 20,000 0.0247% | $4.37 | $87,400 | +35.32% | ||||
| 2019-12-09 | 5,000 0.0062% | $4.39 | $21,950 | +35.32% | ||||
| 2019-12-09 | 2,500 0.0031% | $4.39 | $10,975 | +35.32% | ||||
| 2019-08-23 | 10,000 0.0124% | $4.95 | $49,500 | +9.13% | ||||
| 2019-08-09 | 10,000 0.0124% | $5.08 | $50,800 | +4.35% | ||||
| 2019-06-07 | Sale | 16,000 0.0197% | $5.58 | $89,280 | -6.77% | |||
| 2019-06-06 | Sale | 17,000 0.0212% | $5.57 | $94,690 | -5.07% | |||
| 2019-06-05 | Sale | 17,000 0.0211% | $5.68 | $96,560 | -6.91% | |||
| 2019-06-05 | Sale | 30,000 0.0374% | $5.70 | $171,000 | -6.91% | |||
| 2019-06-04 | 12,500 0.0152% | $5.74 | $71,750 | -9.79% | ||||
| 2018-11-16 | 5,000 0.0063% | $5.58 | $27,900 | +1.07% | ||||
| 2018-11-13 | Sale | 31,099 0.0384% | $5.29 | $164,514 | +5.22% | |||
| 2018-11-12 | Sale | 18,901 0.0238% | $4.96 | $93,749 | +14.40% | |||
| 2018-11-12 | 10,000 0.0127% | $5.01 | $50,100 | +14.40% | ||||
| 2018-11-12 | 15,000 0.0198% | $5.20 | $78,000 | +14.40% | ||||
| 2015-09-24 | Sale | Chief Executive Officer | 20,000 0.0359% | $1.21 | $24,200 | -33.60% | ||
| 2015-09-01 | Sale | Chief Executive Officer | 20,000 0.0368% | $1.32 | $26,400 | -37.59% |
Insider Historical Profitability
| MacAndrews & Forbes Holdings Inc. | 13509722 18.9199% | $6.05 | 6 | 0 | <0.0001% | |
| ROSE ERIC A MD | Chief Executive Officer | 582897 0.8163% | $6.05 | 3 | 7 | +78.38% |
| KASTEN BERNARD L | Chief Executive Officer | 553559 0.7752% | $6.05 | 1 | 0 | <0.0001% |
| Gomez Phillip Louis III | 475782 0.6663% | $6.05 | 2 | 0 | +24.86% | |
| SAVAS PAUL G | 292847 0.4101% | $6.05 | 8 | 0 | +5.42% |
Institutional Investor Ownership
| BlackRock | $29.58M | 4.86 | 3.46M | -1.67% | -$501,453.34 | <0.01 | |
| First Wilshire Securities Management Inc | $22.72M | 3.73 | 2.65M | +12.37% | +$2.5M | 6.68 | |
| The Vanguard Group | $19.55M | 3.21 | 2.28M | +1.85% | +$355,368.42 | <0.0001 | |
| Kempen Capital Management N V | $18.86M | 3.1 | 2.2M | -3.12% | -$606,484.55 | 0.24 | |
| AltraVue Capital LLC | $17.49M | 2.87 | 2.04M | 0% | +$0 | 1.9 |